I apologize for my initial reaction. I was on investor hub and MXAMDUD is spreading so many half truths and lies that I was a bit revved up. Oralogik is and will be a MAJOR breakthrough in drug delivery moving forward. IPIX will boom being partnered with this BDD technology. It's a major breakthrough for IBS sufferers that they've discovered how to pinpoint deliver to various areas of the colon. It's actually a positive thing that it does not release into the blood stream upon swallowing. That would lead to more toxicities and unrelated problems, in addition to lessening the positive effects it would have once reaching the targeted area in the colon. A pill for IBS, and a rinse and spit for mucositis should literally make big pharma stand up and take notice! Both markets are in the billions, and both markets are untapped!! (first IBS oral). These are both major markets that entire companies are based upon, and IPIX has two!!! These are NOT rare disease , these drugs if /when FDA and EMA approved will be unbelievable. What we need now is VISIBILITY amongst big investors and Big Pharma!!! Let's hope Locust Walk is doing this as we speak. The science is good, we just need cash to move into phase 3.